First human tests begin for experimental drug YN001
NCT ID NCT07190885
Summary
This is a very early, first-in-human study to understand how a new drug called YN001 moves through the body and how safe it is. It will involve 24 healthy adult volunteers who will receive a single dose. The main goal is to measure the drug's levels in the blood over time and check for any side effects to see if it's safe for further testing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CMAX Clinical Research
RECRUITINGAdelaide, South Australia, Australia
Contact
Conditions
Explore the condition pages connected to this study.